Invivyd (IVVD) Shares Repurchased (2022 - 2023)
Invivyd posted quarterly Shares Repurchased of $1000.0 for Q2 2023, down 50.0% year-on-year from $2000.0 in Q2 2022, and down 50.0% on a QoQ basis from $2000.0 in Q2 2022.
Invivyd (IVVD) has 2 years of Shares Repurchased data on file, last reported at $1000.0 in Q2 2023.
- For the quarter ending Q2 2023, Shares Repurchased fell 50.0% year-over-year to $1000.0; the trailing twelve-month figure through Sep 2024 stood at $1000.0 (changed 0.0% YoY), and the FY2023 full-year result was $1000.0, down 75.0% from the prior year.
- Shares Repurchased for Q2 2023 stood at $1000.0, down from $2000.0 in the prior quarter.
- Across five years, Shares Repurchased topped out at $2000.0 in Q1 2022 and bottomed at $1000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |